Senseonics Holdings (SENS) Amortization - Deferred Charges (2019 - 2020)
Senseonics Holdings (SENS) reported Amortization - Deferred Charges of $11.5 million for Q4 2020, up 1134.16% on a QoQ basis from $931000.0 in Q3 2020.
Senseonics Holdings (SENS) has 2 years of Amortization - Deferred Charges data on file, last reported at $11.5 million in Q4 2020.
- Quarterly Amortization - Deferred Charges changed N/A year-over-year to $11.5 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $15.8 million (changed N/A YoY) and the FY2020 annual result came in at $12.7 million, up 279.96% from the prior year.
- Amortization - Deferred Charges grew to $11.5 million in Q4 2020 per SENS's latest filing, from $931000.0 in the prior quarter.
- Across five years, Amortization - Deferred Charges topped out at $11.5 million in Q4 2020 and bottomed at $931000.0 in Q3 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortization - Deferred Charges (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Senseonics Holdings | 316.18 Mn | 251.85 Mn | 6.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 11.49 Mn |
| Dec 31, 2020 | 11.49 Mn |
| Sep 30, 2020 | 931,000.00 |
| Sep 30, 2020 | 931,000.00 |
| Sep 30, 2019 | 3.34 Mn |
| Sep 30, 2019 | 3.34 Mn |